NEW YORK CITY, NY / ACCESS Newswire / February 20, 2025 / Aspire Biopharma, Inc. ("Aspire" or the "Company"), a developer of a multi-faceted patent-protected disruptive drug delivery mechanism ...
Quantum BioPharma shares soared after its licensee, Celly Nutrition, engaged a New York investment bank to raise $10 million. Quantum BioPharma holds a 25.71% stake in Celly Nutrition and earns ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback